Abstract
The term neurolymphomatosis (NL) encompasses nerve infiltration by neurotropic neoplastic cells in the setting of an unknown or a known hematologic malignancy. It is a rare neurologic manifestation of non-Hodgkin lymphoma (NHL) and leukemia with a poorly defined incidence. The typical manifestations of NL are of a neuropathy that may affect peripheral nerves, nerve roots, plexus, or cranial nerves. The most common presentations include painful peripheral neuropathy or radiculopathy, cranial neuropathy, painless polyneuropathy and peripheral mononeuropathy or a mononeuropathy multiplex. Successful therapy is contingent upon the recognition of this unique neurological complication, yet the diagnosis is difficult and often elusive. Of all diagnostic tools, imaging studies are of greatest clinical utility. MRI yields abnormal findings in ∼80% of affected patients and FDG-PET appears to be a highly sensitive diagnostic method facilitating identification of NL. There is no known standard treatment for NL and therefore, optimal management is ill-defined. Treatment of NL consists of either chemotherapy alone or combined with radiotherapy. An aggressive multimodality therapy can prevent neurological deterioration and is associated with a prolonged survival in a subset of patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Baehring J, Cooper D (2004) Neurolymphomatosis. J Neurooncol 68(3):243–244
Baehring JM, Damek D, Martin EC, Betensky RA, Hochberg FH (2003) Neurolymphomatosis. Neuro Oncol 5(2):104–115
Bezier M, Reguiai Z, Delaby P, Laroche L, Said G, Bernard P, Grange F (2009) Neurolymphomatosis associated with Sezary syndrome. Arch Dermatol 145(3):294–296
Borit A, Altrocchi PH (1971) Recurrent polyneuropathy and neurolymphomatosis. Arch Neurol 24(1):40–49
Bulsara KR, Kadri PA, Husain M, Al-Mefty O (2005) Malignant lymphoma of the trigeminal region. Case illustration. J Neurooncol 73(3):279–280
Czepczynski R, Guzikowska-Ruszkowska I, Sowinski J (2008) Neurolymphomatosis detected by (18)F-FDG PET/CT scan – a case report. Nucl Med Rev Cent East Eur 11(2):73–75
Dakwar E, Teja S, Alleyne CH Jr, Alleyne CG (2004) Sciatic neurolymphomatosis. Neurology 63(9):1751
Diaz-Arrastia R, Younger DS, Hair L, Inghirami G, Hays AP, Knowles DM, Odel JG, Fetell MR, Lovelace RE, Rowland LP (1992) Neurolymphomatosis: a clinicopathologic syndrome re-emerges. Neurology 42(6):1136–1141
Dong Q, Wong KK, Avram AM (2008) Sacral nerve root neurolymphomatosis diagnosed on FDG-PET/CT and magnetic resonance imaging. Clin Nucl Med 33(1):30–31
Drillenburg P, Pals ST (2000) Cell adhesion receptors in lymphoma dissemination. Blood 95(6):1900–1910
Grisariu S, Avni B, Batchelor TT, van den Bent MJ, Bokstein F, Schiff D, Kuittinen O, Chamberlain MC, Roth P, Nemets A, Shalom E, Ben-Yehuda D, Siegal T (2010) Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report. Blood 115(24):5005–5011
Grisold W, Jellinger K, Jellinger K, Lutz D (1990) Human neurolymphomatosis in a patient with chronic lymphatic leukemia. Clin Neuropathol 9(5):224–230
Iplikcioglu AC, Dinc C, Bikmaz K, Ozcan D (2006) Primary lymphoma of the trigeminal nerve. Br J Neurosurg 20(2):103–105
Julien S, Radosavljevic M, Labouret N, Camilleri-Broet S, Davi F, Raphael M, Martin T, Pasquali JL (1999) AIDS primary central nervous system lymphoma: molecular analysis of the expressed VH genes and possible implications for lymphomagenesis. J Immunol 162(3):1551–1558
Karadag D, Karagulle AT, Erden I, Erden A (2002) Trigeminal nerve involvement in T-cell acute lymphoblastic leukemia: value of MR imaging. Eur J Radiol 44(1):16–18
Khong P, Pitham T, Owler B (2008) Isolated neurolymphomatosis of the cauda equina and filum terminale: case report. Spine 33(21):E807–E811
Kim JH, Jang JH, Koh SB (2006) A case of neurolymphomatosis involving cranial nerves: MRI and fusion PET-CT findings. J Neurooncol 80(2):209–210
Kinoshita M, Izumoto S, Oshino S, Nonaka M, Moriuchi S, Maruno M, Yoshimine T (2003) Primary malignant lymphoma of the trigeminal region treated with rapid infusion of high-dose MTX and radiation: case report and review of the literature. Surg Neurol 60(4):343–348; discussion 348
Kitzmann AS, Pulido JS, Garrity JA, Witzig TE (2008) Histologic findings in T-cell lymphoma infiltration of the optic nerve. Ophthalmology 115(5):e1–e6
Kosa SC, Peller PJ, Klein CJ (2009) T-cell neurolymphomatosis involving cauda equina and sciatic nerves. Neurology 72(1):98
Kuntzer T, Lobrinus JA, Janzer RC, Ghika J, Bogousslavsky J (2000) Clinicopathological and molecular biological studies in a patient with neurolymphomatosis. Muscle Nerve 23(10):1604–1609
Kuroda Y, Nakata H, Kakigi R, Oda K, Shibasaki H, Nakashiro H (1989) Human neurolymphomatosis by adult T-cell leukemia. Neurology 39(1):144–146
Larocca LM, Capello D, Rinelli A, Nori S, Antinori A, Gloghini A, Cingolani A, Migliazza A, Saglio G, Cammilleri-Broet S, Raphael M, Carbone A, Gaidano G (1998) The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells. Blood 92(3):1011–1019
Levin N, Soffer D, Grissaru S, Aizikovich N, Gomori JM, Siegal T (2008) Primary T-cell CNS lymphoma presenting with leptomeningeal spread and neurolymphomatosis. J Neurooncol 90(1):77–83
Matano S, Shirasaki H, Terahata S, Nobata K, Sugimoto T (2006) Thickening of multiple cranial nerves in a patient with extranodal peripheral T-cell lymphoma. J Neuroimaging 16(2):167–169
McCann KJ, Ashton-Key M, Smith K, Stevenson FK, Ottensmeier CH (2009) Primary central nervous system lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development. Blood 113(19):4677–4680
Montesinos-Rongen M, Kuppers R, Schluter D, Spieker T, Van Roost D, Schaller C, Reifenberger G, Wiestler OD, Deckert-Schluter M (1999) Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment. Am J Pathol 155(6):2077–2086
Moore KR, Blumenthal DT, Smith AG, Ward JH (2001) Neurolymphomatosis of the lumbar plexus: high-resolution MR neurography findings. Neurology 57(4):740–742
Odabasi Z, Parrott JH, Reddy VV, Oh SJ (2001) Neurolymphomatosis associated with muscle and cerebral involvement caused by natural killer cell lymphoma: a case report and review of literature. J Peripher Nerv Syst 6(4):197–203
Okada K, Tanaka Y, Murakami K, Chiba S, Morimura T, Hattori M, Goryo M, Onuma M (1997) Phenotype analysis of lymphoid cells in Marek’s disease of CD4(+) or CD8(+) T-cell-deficient chickens: occurrence of double negative T-cell tumour. Avian Pathol 26(3):525–534
Osterrieder N, Kamil JP, Schumacher D, Tischer BK, Trapp S (2006) Marek’s disease virus: from miasma to model. Nat Rev Microbiol 4(4):283–294
Ozturk E, Arpaci F, Kocaoglu M, Arslan N, Bulakbasi N, Ozguven M (2006) Detection of widespread neurolymphomatosis with 18F-FDG PET. Eur J Nucl Med Mol Imaging 33(8):975–976
Pages M, Marty-Double C, Pages AM (2004) Sensory neuropathy as revealing symptom of neurolymphomatosis: report of a case with a 15-year duration. Eur Neurol 52(1):57–58
Pals ST, Drillenburg P, Radaszkiewicz T, Manten-Horst E (1997) Adhesion molecules in the dissemination of non-Hodgkin’s lymphomas. Acta Haematol 97(1–2):73–80
Shima K, Ishida C, Okino S, Kotani T, Higashi K, Yamada M (2008) A linear lesion along the brachial plexus on FDG-PET in neurolymphomatosis. Intern Med 47(12):1159–1160
Strobel K, Fischer K, Hany TF, Poryazova R, Jung HH (2007) Sciatic nerve neurolymphomatosis – extent and therapy response assessment with PET/CT. Clin Nucl Med 32(8):646–648
Tajima Y, Sudo K, Matumoto A (2007) Malignant lymphoma originating in the cauda equina mimicking the inflammatory polyradiculoneuropathy. Intern Med 46(13):1029–1032
Yazawa S, Ohi T, Shiomi K, Takashima N, Kyoraku I, Nakazato M (2007) Brachial plexus neurolymphomatosis: a discrepancy between electrophysiological and radiological findings. Intern Med 46(8):533–534
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Siegal, T. (2012). Neurolymphomatosis: Diagnosis, Treatment, and Outcome. In: Hayat, M. (eds) Tumors of the Central Nervous System, Volume 9. Tumors of the Central Nervous System, vol 9. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-5488-1_1
Download citation
DOI: https://doi.org/10.1007/978-94-007-5488-1_1
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-5487-4
Online ISBN: 978-94-007-5488-1
eBook Packages: MedicineMedicine (R0)